Initial skin cancer screening for solid organ transplant recipients in the United States: Delphi method development of expert consensus guidelines
- PMID: 31502728
- DOI: 10.1111/tri.13520
Initial skin cancer screening for solid organ transplant recipients in the United States: Delphi method development of expert consensus guidelines
Abstract
Skin cancer is the most common malignancy affecting solid organ transplant recipients (SOTR), and SOTR experience increased skin cancer-associated morbidity and mortality. There are no formal multidisciplinary guidelines for skin cancer screening after transplant, and current practices are widely variable. We conducted three rounds of Delphi method surveys with a panel of 84 U.S. dermatologists and transplant physicians to establish skin cancer screening recommendations for SOTR. The transplant team should risk stratify SOTR for screening, and dermatologists should perform skin cancer screening by full-body skin examination. SOTR with a history of skin cancer should continue regular follow-up with dermatology for skin cancer surveillance. High-risk transplant patients include thoracic organ recipients, SOTR age 50 and above, and male SOTR. High-risk Caucasian patients should be screened within 2 years after transplant, all Caucasian, Asian, Hispanic, and high-risk African American patients should be screened within 5 years after transplant. No consensus was reached regarding screening for low-risk African American SOTR. We propose a standardized approach to skin cancer screening in SOTR based on multidisciplinary expert consensus. These guidelines prioritize and emphasize the need for screening for SOTR at greatest risk for skin cancer.
Keywords: Delphi method; consensus; guidelines; post-transplant malignancy; skin cancer screening; solid organ transplant recipients.
© 2019 Steunstichting ESOT.
Comment in
-
How to take the skin cancer risk of your transplant patient seriously.Transpl Int. 2019 Dec;32(12):1244-1246. doi: 10.1111/tri.13541. Transpl Int. 2019. PMID: 31610049 No abstract available.
References
-
- Berg D, Otley CC. Skin cancer in organ transplant recipients: epidemiology, pathogenesis, and management. J Am Acad Dermatol 2002; 47: 1; quiz 18-20.
-
- Garrett GL, Blanc PD, Boscardin J, et al. Incidence of and risk factors for skin cancer in organ transplant recipients in the United States. JAMA Dermatol 2017; 153: 296.
-
- 2016 Annual Report [Internet]. United Network for Organ Sharing, Organ Procurement and Transplantation Network; 2017. Available from: http://optn.transplant.hrsa.gov/latestData/rptData.asp
-
- Garrett GL, Lowenstein SE, Singer JP, He SY, Arron ST. Trends of skin cancer mortality after transplantation in the United States: 1987 to 2013. J Am Acad Dermatol 2016; 75: 106.
-
- Acuna SA, Huang JW, Scott AL, et al. Cancer screening recommendations for solid organ transplant recipients: a systematic review of clinical practice guidelines. Am J Transplant 2017; 17: 103.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
